Clincosm LogoSign in Get a demo

READ-COG BPCO: Pulmonary Rehabilitation, Dyspnoea and Emotional Cognition in COPD

Sponsor
Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil (Other)
Overall Status
Completed
CT.gov ID
NCT03092700
Collaborator
(none)
20
Enrollment
1
Location
4.4
Actual Duration (Months)
4.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To evaluate whether pulmonary rehabilitation improves emotional cognition, using facial emotions recognition and smile production, by improving the emotional dimension of dyspnoea in patients with chronic obstructive pulmonary disease (COPD).To evaluate whether pulmonary rehabilitation improves emotional cognition, using facial emotions recognition and smile production, by improving the emotional dimension of dyspnoea in patients with chronic obstructive pulmonary disease (COPD).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The aim of the study will be to evaluate the effect of pulmonary rehabilitation on dyspnoea emotional component and on emotional cognition. It will add a better understanding of the mechanisms of pulmonary rehabilitation on dyspnoea.

    Patients with COPD will be included before starting a pulmonary rehabilitation and be evaluated with questionnaires (including the Multidimensional Dyspnea Profile, and quality of life questionnaires), emotional cognition (at rest and right after an endurance test, using some short movies sequences and pictures of faces expressing some well defined emotions) and smile production analysis.

    After having followed a pulmonary rehabilitation, the same evaluation will be realised and results will be compared before and after the intervention.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    20 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Effects of Pulmonary Rehabilitation on Dyspnoea Affective Dimension and Emotional Cognition in Patients With Chronic Obstructive Pulmonary Disease
    Actual Study Start Date :
    Apr 5, 2017
    Actual Primary Completion Date :
    Aug 16, 2017
    Actual Study Completion Date :
    Aug 16, 2017

    Outcome Measures

    Primary Outcome Measures

    1. emotional cognition [6 weeks]

      Emotional cognition in patients with chronic dyspnoea using time to recognize some emotions on short movies and pictures of facial emotions.

    Secondary Outcome Measures

    1. Correlation between physical improvement, quality of life improvement and time to recognize facial emotions. [6 weeks]

      Correlations

    2. Correlations between physical improvement and production of the smile. [6 weeks]

      Correlations

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • COPD patients with pulmonary rehabilitation indication, hospitalized in Department of Pulmonary Diseases in La Pitié-Salpêtrière, Paris, France.

    • Age of 40 at least.

    Exclusion Criteria:

    • Facial paralysis

    • Neuromuscular disease

    • Contraindication for pulmonary rehabilitation

    • Severe depression syndrom or psychiatric disease

    • Drug use

    • Impaired vision

    • Higher functions disorders (Mini Mental Score Examination < 26)

    • Severe obesity (BMI>40kg/m²)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Centre d'Investigation Clinique Paris Est, Groupe Hospitalier Pitié-Salpêtrière Paris France 75013

    Sponsors and Collaborators

    • Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
    ClinicalTrials.gov Identifier:
    NCT03092700
    Other Study ID Numbers:
    • 2017-A00045-48
    First Posted:
    Mar 28, 2017
    Last Update Posted:
    Feb 24, 2021
    Last Verified:
    Feb 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Dyspnea
    Affective Symptoms

    Study Results

    No Results Posted as of Feb 24, 2021